Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 May 19:9:9-21.
doi: 10.1016/j.ynstr.2018.05.003. eCollection 2018 Nov.

Chronic stress as a risk factor for Alzheimer's disease: Roles of microglia-mediated synaptic remodeling, inflammation, and oxidative stress

Kanchan Bisht  1 , Kaushik Sharma  1 , Marie-Ève Tremblay  1   2
Affiliations
Review

Chronic stress as a risk factor for Alzheimer's disease: Roles of microglia-mediated synaptic remodeling, inflammation, and oxidative stress

Kanchan Bisht et al. Neurobiol Stress. .

Abstract

Microglia are the predominant immune cells of the central nervous system (CNS) that exert key physiological roles required for maintaining CNS homeostasis, notably in response to chronic stress, as well as mediating synaptic plasticity, learning and memory. The repeated exposure to stress confers a higher risk of developing neurodegenerative diseases including sporadic Alzheimer's disease (AD). While microglia have been causally linked to amyloid beta (Aβ) accumulation, tau pathology, neurodegeneration, and synaptic loss in AD, they were also attributed beneficial roles, notably in the phagocytic elimination of Aβ. In this review, we discuss the interactions between chronic stress and AD pathology, overview the roles played by microglia in AD, especially focusing on chronic stress as an environmental risk factor modulating their function, and present recently-described microglial phenotypes associated with neuroprotection in AD. These microglial phenotypes observed under both chronic stress and AD pathology may provide novel opportunities for the development of better-targeted therapeutic interventions.

Keywords: ABCA7, ATP-binding cassette transporter A7; AD, Alzheimer's disease; APOE, Apolipoprotein E; APP, amyloid precursor protein; Alzheimer's disease; Aβ, Amyloid beta; BDNF, brain derived neurotrophic factor; CD11b, cluster of differentiation molecule 11B; CD33, cluster of differentiation 33; CNS, central nervous system; CR, complement receptor; CRF, corticotropin releasing factor; DAM, disease associated microglia; DAP12, DNAX-activation protein 12; Dark microglia; FAD, Familial Alzheimer's disease; FCRLS, Fc receptor-like S scavenger receptor; GR, glucocorticoid receptor; HPA axis, hypothalamic pituitary adrenocortical axis; IBA1, ionized calcium-binding adapter molecule 1; IL, interleukin; LTP, long-term potentiation; MGnD, microglia with a neurodegenerative phenotype; MR, mineralocorticoid receptor; Microglia; Microglial phenotypes; NADPH, nicotinamide adenine dinucleotide phosphate; NFT, neurofibrillary tangles; Neurodegeneration; Neuroinflammation; PS, presenilin; ROS, reactive oxygen species; Stress; Synaptic remodeling; TGFβ, transforming growth factor β; TLR, Toll-like receptors; TMEM119, transmembrane protein 119; TNFα, tumor necrosis factor-α; TREM2, triggering receptor expressed in myeloid cells 2; TYROBP, TYRO protein tyrosine kinase binding protein; mPFC, medial prefrontal cortex.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Overview of the AD pathology mouse models mentioned in the review. Data compiled from Alzforum Alzheimer's disease research model database (https://www.alzforum.org/research-models/alzheimers-disease).
Fig. 2
Fig. 2
Overview of microglial functions in response to stress and AD pathology.
See this image and copyright information in PMC

References

    1. Abe-Dohmae S., Ikeda Y., Matsuo M., Hayashi M., Okuhira K., Ueda K., Yokoyama S. Human ABCA7 supports apolipoprotein-mediated release of cellular cholesterol and phospholipid to generate high density lipoprotein. J. Biol. Chem. 2004;279:604–611. - PubMed
    1. Alkadhi K.A. Chronic psychosocial stress exposes Alzheimer's disease phenotype in a novel at-risk model. Front. Biosci. 2012;4:214–229. - PubMed
    1. Ard M.D., Cole G.M., Wei J., Mehrle A.P., Fratkin J.D. Scavenging of Alzheimer's amyloid beta-protein by microglia in culture. J. Neurosci. Res. 1996;43:190–202. - PubMed
    1. Aschbacher K., O'Donovan A., Wolkowitz O.M., Dhabhar F.S., Su Y., Epel E. Good stress, bad stress and oxidative stress: insights from anticipatory cortisol reactivity. Psychoneuroendocrinology. 2013;38:1698–1708. - PMC - PubMed
    1. Atagi Y., Liu C.-C., Painter M.M., Chen X.-F., Verbeeck C., Zheng H., Li X., Rademakers R., Kang S.S., Xu H., Younkin S., Das P., Fryer J.D., Bu G. Apolipoprotein E is a ligand for triggering receptor expressed on myeloid cells 2 (TREM2) J. Biol. Chem. 2015;290:26043–26050. - PMC - PubMed

Further reading

    1. Andorfer C., Kress Y., Espinoza M., de Silva R., Tucker K.L., Barde Y.-A., Duff K., Davies P. Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms. J. Neurochem. 2003;86:582–590. - PubMed
    1. Chishti M.A., Yang D.S., Janus C., Phinney A.L., Horne P., Pearson J., Strome R., Zuker N., Loukides J., French J., Turner S., Lozza G., Grilli M., Kunicki S., Morissette C., Paquette J., Gervais F., Bergeron C., Fraser P.E., Carlson G.A., George-Hyslop P.S., Westaway D. Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J. Biol. Chem. 2001;276:21562–21570. - PubMed
    1. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., Cole G. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science. 1996;274:99–102. - PubMed
    1. Jankowsky J.L., Slunt H.H., Ratovitski T., Jenkins N.A., Copeland N.G., Borchelt D.R. Co-expression of multiple transgenes in mouse CNS: a comparison of strategies. Biomol. Eng. 2001;17:157–165. - PubMed
    1. Lambourne S.L., Sellers L.A., Bush T.G., Choudhury S.K., Emson P.C., Suh Y., Wilkinson L.S. Increased tau phosphorylation on mitogen-activated protein kinase consensus sites and cognitive decline in transgenic models for Alzheimer's disease and FTDP-17: evidence for distinct molecular processes underlying tau abnormalities. Mol. Cell Biol. 2005;25:278–293. - PMC - PubMed